← Back to Search

Physiotherapy for Painful Intercourse

N/A
Waitlist Available
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2-week post-treatment assessment
Awards & highlights

Summary

Gynecological cancers represent more than half of female cancers. It has been clearly established that cancer survivors suffer from important health issues such as pain during sexual intercourse (dyspareunia) and sexual dysfunctions which sorely impact their quality of life. Although it affects more than 63% of cancer survivors, the available treatments remain limited and poorly studied. Cancer survivors are thus confronted with these health issues as well as relationship difficulties and psychological consequences, with limited treatment avenues. Addressing pelvic floor muscle dysfunctions and loss of vaginal elasticity, pelvic floor physiotherapy was shown to be effective in reducing or even alleviating dyspareunia and improving sexual function. Until now, no study investigated this treatment in gynecological cancer survivors with dyspareunia. Therefore, there is a need to examine pelvic floor physiotherapy to determine whether or not gynecological cancer survivors with dyspareunia could benefit from this treatment. The objectives of this single-arm mixed-method study are to evaluate the acceptability and feasibility of a physiotherapy treatment in gynecological cancer survivors suffering from dyspareunia and to explore treatment effects. This single-arm study using mixed methods will involve three data collections (pre- and post-treatment assessments). These assessments will be carried out by physiotherapists. Participants will receive physiotherapy treatment weekly in individual 60-minute sessions for 12 weeks. Thirty-one gynecological cancer survivors with vulvovaginal pain during sexual intercourse for at least 3 months will be recruited. The results of this study will bring new information regarding physiotherapy treatment for this population in preparation for a definitive randomized controlled trial.

Eligible Conditions
  • Painful Intercourse
  • Gynecological Cancers

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-week post-treatment assessment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2-week post-treatment assessment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence rates
Retention rate
Secondary study objectives
Adverse events
Change from baseline in pain
Change from baseline in pelvic floor muscle function
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: PhysiotherapyExperimental Treatment1 Intervention
12 weekly 60-minute individual sessions of multimodal physiotherapy including education, stretching techniques, pelvic floor muscle biofeedback as well as home exercises.

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
302 Previous Clinical Trials
70,232 Total Patients Enrolled
Centre de recherche du Centre hospitalier universitaire de SherbrookeOTHER
61 Previous Clinical Trials
33,483 Total Patients Enrolled
Institut Universitaire de Gériatrie de MontréalOTHER
2 Previous Clinical Trials
89 Total Patients Enrolled
~3 spots leftby Sep 2025